6855 — Ascentage Pharma International Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$6.28bn
- HK$6.40bn
- CNY209.71m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -347 | -1,482 | -675 | -832 | -887 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 63.7 | 984 | 85.8 | 13.4 | 67.4 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 27.1 | 11.1 | -47.7 | 186 | 104 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -238 | -460 | -610 | -605 | -654 |
Capital Expenditures | -49.5 | -81.4 | -251 | -457 | -257 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 342 | -120 | 144 | -9.89 | -128 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 293 | -201 | -107 | -467 | -385 |
Financing Cash Flow Items | -6.52 | -32.3 | -19.3 | -32.9 | -49.8 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 860 | 442 | 1,040 | 1,781 | 619 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 942 | -218 | 281 | 687 | -361 |